Homozygous Deletion Mapping in Myeloma Samples Identifies Genes and an Expression Signature Relevant to Pathogenesis and Outcome

PURPOSE: Myeloma is a clonal malignancy of plasma cells. Poor prognosis risk is currently identified by clinical and cytogenetic features. However, these indicators do not capture all prognostic information. Gene expression analysis can be used to identify poor prognosis patients and this can be imp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dickens, Nicholas J., Walker, Brian A., Leone, Paola E., Johnson, David C., Brito, José L., Zeisig, Athanasia, Jenner, Matthew W, Boyd, Kevin D, Gonzalez, David, Gregory, Walter M., Ross, Fiona M., Davies, Faith E., Morgan, Gareth J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2841345/
https://ncbi.nlm.nih.gov/pubmed/20215539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-2831
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados